The Europe animal healthcare market includes pharmaceuticals as well as vaccines to prevent diseases. The market for animal healthcare is witnessing substantial growth owing to rising concerns over zoonotic diseases and animal welfare. Some key advantages of animal healthcare products includes provision of preventative healthcare, cure various animal illnesses and infections, ensure safety, welfare and health of animals. There is an increasing need for animal vaccination, parasiticides and anti-infectives to control zoonotic & vector-borne diseases. The Global Europe animal healthcare market is estimated to be valued at US$ 14,096.3 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030.

Key Takeaways
Key players operating in the Europe animal healthcare are Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company. These players are focusing on new product launches and regulatory approvals to strengthen their market position. For instance, in 2022, Zoetis Inc. received approval from the European Commission for its pain management product Anesticare.

The Europe animal healthcare market is witnessing robust growth in demand for pet care treatment. Rising pet ownership across the region coupled with growing expenditure on animal health is fueling the market growth. According to European Pet Food Industry Federation, around 260 million pets were owned in Europe in 2021, out of which 89 million were dogs and 150 million were cats.

Technological advancements in drug delivery systems and diagnosis are boosting the Europe animal healthcare market. Key players are increasingly investing in R&D to develop novel drugs and vaccines with minimally invasive drug delivery systems. For example, in 2021, Dechra Pharmaceuticals developed a slow-release transdermal gel to treat pain and inflammation in horses.

Market Trends
Growing veterinary telehealth and online pharmacy trends across Europe owing to advantages such as convenience and cost savings.
Rising adoption of pet insurance to offset escalating veterinary costs thereby driving demand for preventive animal care and vaccinations.

Market Opportunities
Potential for development of advanced drug delivery systems including transdermal patches and novel formulations.
Growing pet nutrition segment in Europe offers immense growth prospects for animal healthcare players to develop nutritional supplements, probiotics and functional pet foods.

To overcome short term challenges, market players are focusing on expanding eCommerce channels and improving digital capabilities. They are ensuring uninterrupted supply of essential medications and vaccines. Governments are supporting farmers through subsidies and financial assistance to boost animal production. Once lockdowns ease, demand from food animals and companion animal segments is projected to bounce back rapidly. Strict hygiene and safety protocols implemented in clinics and farms will help regain consumer confidence. Long term strategies include increasing research spending on new disease treatments, preventive vaccines, growth promotors etc. Partnerships with technology companies and veterinary distributors will help strengthen market position in post-Covid scenario.

In terms of value, Europe Animal Healthcare market is concentrated majorly in Western Europe led by countries like Germany, UK, France, Italy and Spain. This region accounted for over 60% market share in 2024 due to strong veterinary infrastructure, rising pet ownership and high per capita meat consumption. Eastern Europe is also an important regional market, expected to grow at a higher rate during forecast period. Countries like Russia, Poland and Turkey are forecasted to drive higher market demand due to increasing livestock farming, improving standards of care and growing focus on ensuring food safety.